Exelixis (EXEL) Deferred Taxes (2018 - 2022)
Exelixis (EXEL) recorded quarterly Deferred Taxes of $60.4 million in Q4 2022, up 294.03% quarter-over-quarter from $15.3 million in Q3 2022, and up 526.14% on a YoY basis from $9.6 million in Q4 2021.
Exelixis (EXEL) Deferred Taxes (2018 - 2022) Analysis & Trends
Exelixis' Deferred Taxes history runs 5 years deep, the most recent figure standing at $60.4 million for Q4 2022.
- In Q4 2022, Deferred Taxes rose 526.14% year-over-year to $60.4 million; the TTM figure through Mar 2023 stood at $75.7 million (up 216.01% YoY), while the FY2026 annual figure was -$126.2 million, down 312.31% from the prior year.
- Deferred Taxes was $60.4 million for Q4 2022 at Exelixis, up from $15.3 million in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $244.1 million in Q4 2018 to a low of -$71.6 million in Q1 2021.
- Historically, Deferred Taxes has averaged $19.4 million across 5 years, with a median of -$3.1 million in 2021.
- Biggest YoY gain for Deferred Taxes was 526.14% in 2022; the steepest drop was 552.13% in 2022.
- A 5-year view of Deferred Taxes shows it stood at $244.1 million in 2018, then plunged by 90.47% to $23.3 million in 2019, then tumbled by 143.52% to -$10.1 million in 2020, then slumped by 39.85% to -$14.2 million in 2021, then jumped by 526.14% to $60.4 million in 2022.
- The last three Deferred Taxes figures came in at $60.4 million (Q4 2022), $15.3 million (Q3 2022), and -$15.3 million (Q2 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | -65.30 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Exelixis | 13.71 Bn | 12.93 Bn | 590.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 30, 2022 | 60.36 Mn |
| Jul 1, 2022 | 15.32 Mn |
| Apr 1, 2022 | -15.32 Mn |
| Dec 31, 2021 | -14.16 Mn |
| Oct 1, 2021 | -9.57 Mn |
| Jul 2, 2021 | -26.19 Mn |
| Apr 2, 2021 | 3.39 Mn |
| Jan 1, 2021 | -71.60 Mn |
| Apr 3, 2020 | -10.13 Mn |
| Sep 27, 2019 | 23.27 Mn |
| Jun 28, 2019 | 33.07 Mn |
| Dec 28, 2018 | 244.11 Mn |